The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Despite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to ...

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

One effective action involves addressing obesity, a major driver of chronic disease and health care costs. Obesity is an ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

A coalition of industry organizations is pressing employers to offer coverage for obesity as they would for other chronic ...

The Canadian Medical Association and the World Health Organization (WHO) consider obesity as a progressive chronic disease ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

India must note that obesity is a public health challenge, waiting for holistic, multipronged and comprehensive interventions ...

Obesity is a chronic, progressive disease that affects one-third of adults in Florida. We cannot afford to continue ignoring ...